جستجوی استاد راهنمای دانشگاهی

• Clinical Toxicology
• Pharmacoepidemiology
• Poisoning
• +۳ مورد دیگر

Professor Nicholas Buckley is a leading academic in Clinical Pharmacology at the University of Sydney and holds a Visiting Professor position at the University of Peradeniya, Sri Lanka. He serves as Research Director for the South Asian Clinical Toxicology Research Collaboration (SACTRC) and is a Consultant Clinical Pharmacologist & Toxicologist at the NSW Poisons Information Centre and Royal Prince Alfred Hospital. His work focuses on improving clinical toxicology practices, poison control policies, and understanding mechanisms of drug toxicity. Co-founder of SACTRC for agrochemical poisoning and snakebite research Chair of Australian Therapeutic Guidelines - Toxicology writing group Editorial roles in Clinical Toxicology, Drug Safety, and Australian Prescriber Research Interests include toxicovigilance, epidemiology of poisoning, acute kidney injury in poisoning/snakebite, pesticide safety interventions, antidote development, and pharmacoepidemiology of psychotropic drugs. His work combines clinical trials, population surveillance, and translational research. Scientific Contributions span 440+ peer-reviewed articles and 22 book chapters, with continuous funding since 2002. He has supervised over 20 higher degree students and leads international collaborations in low-and-middle-income countries through NIHR RIGHT4. Key Affiliations : Member of Charles Perkins Centre, Australian Medicines Handbook Editorial Advisory Board, and NIHR RIGHT4 programme.

Kora DeBeckمشاهده پروفایل

استاد

• Substance Use
• Drug Policy
• Health Policy
• +۳ مورد دیگر

Kora DeBeck is a Distinguished Professor of Substance Use and Drug Policy in the School of Public Policy at Simon Fraser University, a CIHR Applied Public Health Chair, and Dorothy Killam Fellow. She is also a Research Scientist with the BC Centre on Substance Use and Principal Investigator of the At-Risk Youth Study (ARYS), a longitudinal cohort tracking over 1,200 street-involved youth. Her research focuses on substance use policy, health services for marginalized populations, and the structural drivers of drug-related harms. She has published over 200 peer-reviewed articles challenging ineffective drug enforcement models and advocating for policy reforms. Recent publications analyze trends in opioid use, harm reduction during the COVID-19 pandemic, drug decriminalization, and youth-focused interventions. Her work consistently addresses social inequities through data-driven approaches to the toxic drug crisis. CIHR Applied Public Health Chair Dorothy Killam Fellow Michael Smith Health Research BC Scholar Award Distinguished SFU Professorship She has secured over $50 million in research funding, including $21M as principal investigator for ARYS. Her lab collaborates with healthcare providers, community organizations, and policymakers to translate research into practice.

• Clinical Psychology
• Health Psychology
• Substance Use Disorders
• +۹ مورد دیگر

Laura Robinson is a Senior Lecturer at the School of Psychology , University of Wollongong. She holds a Doctor of Philosophy in Psychology and extensive teaching experience in behavioral sciences, statistics, and applied psychology. Education : PhD in Psychology (2017), Postgraduate Diploma in Psychology (2010), Bachelor of Psychology (2009), and Bachelor of Aviation (2004) Her research focuses on vulnerable populations, particularly women and youth, with expertise in substance use disorders, eating disorders, mental health comorbidity, and health equity. She has published extensively on residential treatment outcomes, continuing care interventions, and stigma reduction in mental healthcare. Recent publications highlight longitudinal analyses of psychological distress, weight stigma, and integrated approaches to substance use and physical health. She supervises PhD students on topics like veterans' mental health, methamphetamine use, and suicide prevention. Laura has received funding from internal and external sources, including grants for stimulant use interventions and health literacy studies. She serves on committees like the Australasian Professional Society for Alcohol and Drugs and contributes to peer-reviewed journals as a reviewer.

• Health Law
• Privacy Law
• Drug Policy
• +۷ مورد دیگر

Jennifer D. Oliva is a Professor of Law at Indiana University Maurer School of Law where she holds the Val Nolan Faculty Fellow position. She maintains significant interdisciplinary affiliations as a Research Scholar at Georgetown University Law Center's O'Neill Institute for National & Global Health Law and as a Senior Scholar with the UCSF/UC Law Consortium on Law, Science & Health Policy. Her academic work bridges legal scholarship with practical health policy development, focusing on the intersection of constitutional protections, public health needs, and modern surveillance technologies. Professor Oliva's research interests center on health law, privacy law, and drug policy with particular expertise in prescription drug monitoring programs (PDMPs), health information privacy, and the legal dimensions of the opioid crisis. Her scholarship critically examines how law enforcement surveillance of prescription data impacts patient privacy rights, particularly for vulnerable populations including those with substance use disorders. She has developed significant expertise in how constitutional privacy protections apply to health data in the digital age, especially following the Supreme Court's decision in Carpenter v. United States. Her recent publications reveal a growing focus on algorithmic regulation in healthcare, examining how risk scoring systems and coverage algorithms can perpetuate health disparities. She has published extensively on the intersection of reproductive rights and health data privacy in the post-Dobbs landscape, analyzing how prescription monitoring systems could be weaponized against individuals seeking reproductive healthcare. Her work consistently connects doctrinal legal analysis with public health realities, advocating for evidence-based policy approaches that prioritize patient privacy and health equity over punitive enforcement. Dosing Discrimination: Regulating PDMP Risk Scores (2022) The "New" Drug War (2024) Prescription Drug Policing: The Right to Health Information Privacy Pre- and Post-Carpenter (2020) Opioid Multidistrict Litigation Secrecy (2019) Surveillance, Privacy, and App Tracking (2020) Professor Oliva actively engages with policymakers and has contributed to amicus briefs in significant cases including Ruan v. United States. Her scholarship has been cited in legal proceedings and she regularly presents at major academic conferences including the Association of American Law Schools Annual Meeting. She has collaborated with scholars across disciplines including public health researchers, medical ethicists, and data scientists to address complex challenges at the intersection of law, technology, and healthcare.

Barbara Givenمشاهده پروفایل

استاد

• Nursing
• Oncology Caregiver Support
• Symptom Management in Cancer Patients
• +۳ مورد دیگر

Barbara Given is a University Distinguished Professor in the College of Nursing at Michigan State University. Her research focuses on the interplay between formal healthcare systems and informal caregiver networks, particularly in oncology and geriatric populations. She has secured over 34 years of NIH funding, including grants from the National Cancer Institute, NIMH, and others. Dr. Given earned her Ph.D. at MSU, following a BSN and MSN from Ohio State University. Her work centers on caregiver burden, symptom management in chronic disease, and caregiver-patient communication. She developed the Caregiver Burden Instrument, widely used in research and clinical settings across multiple languages. Key research interests include: 1) caregiver stress and support systems, 2) symptom management in cancer patients, and 3) healthcare coordination challenges in aging populations. Her NIH-funded projects address adherence to oral chemotherapy, fall prevention in cancer survivors, and psychosocial outcomes post-treatment. Recent articles emphasize innovation in symptom tracking (e.g., text messaging for adherence), caregiver mental health barriers, and longitudinal symptom analysis. Awards/fellowships are not explicitly stated, though her sustained NIH support reflects significant recognition. Dr. Given advises on grants and mentors nurse researchers. She collaborates on interdisciplinary teams focused on palliative care, gerontology, and technology-based interventions. Her work bridges clinical practice and policy, advocating for integrated care models to reduce caregiver burden.

Samantha J. Harrisمشاهده پروفایل

دانشگاهی

• Health Policy
• Health Services Research
• Substance Use Treatment
• +۸ مورد دیگر

Samantha J. Harris, PhD, MPA, is an Assistant Scientist in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Her primary appointment is with the Bloomberg Overdose Prevention Initiative, where she leads state-level evaluations in Kentucky and New Mexico, focusing on overdose prevention and implementation of harm reduction policies. Institution: Johns Hopkins University School: Bloomberg School of Public Health Department: Department of Health Policy and Management Position: Assistant Scientist Education: PhD in Health Policy, University of Georgia, 2021 MPA in Health Policy, University of Kentucky, 2016 BA in Arts Administration, University of Kentucky, 2014 Postdoctoral Training, Johns Hopkins Bloomberg School of Public Health Samantha Harris's research centers on improving access to mental health and substance use treatment, particularly through public insurance programs like Medicaid and Medicare. Her work applies mixed-methods approaches to evaluate policies related to harm reduction, overdose prevention, and service delivery within the criminal legal system. She has a strong interest in aging and health, opioid and alcohol use disorders, and equitable access to care. Her recent publications highlight trends in Medicare coverage for methadone and buprenorphine, implementation of syringe services programs, and attitudes toward decriminalization policies. Her work spans qualitative and quantitative methods, often focusing on policy impact and implementation barriers at the state level. Scientific Contributions: Lead researcher on rapid-cycle evaluations of overdose prevention programs Co-Investigator on NIH, SAMHSA, and privately funded projects Frequent collaborator with interdisciplinary teams and state agencies Harris has served in policy-focused fellowship placements and contributes to high-impact journals such as Health Affairs and Drug and Alcohol Dependence . She advises on policy evaluation and health services research but no formal students are listed. She is actively involved in the Bloomberg Overdose Prevention Initiative, working closely with Dr. Brendan Saloner and Dr. Sachini Bandara. Her lab or team is embedded within this initiative, conducting real-time assessments of innovative state policies to reduce fatal overdoses.

Basak Tasمشاهده پروفایل

پژوهشگر ارشد

• Opioid overdose and its underlying mechanisms
• Opioid use disorder and related treatment
• Health interventions tackling drug-related morbidity and mortality
• +۲ مورد دیگر

Dr. Basak Tas is a Research Fellow at King's College London, based in the Institute of Psychiatry, Psychology & Neuroscience within the Department of Addictions Sciences. She has been working at King's since 2014, initially as a PhD student and then as a Post-doctoral Research Associate, before taking up her current role in 2021. Her work focuses on opioid overdose and related interventions, collaborating with Professor Sir John Strang and Dr. Will Lawn. Her educational background includes an undergraduate degree in Neuroscience from King's College London and an MSc in Neuroscience from the University of Edinburgh. She completed her PhD at King's College London under the supervision of Professor Sir John Strang, Dr. Caroline Jolley, and Dr. James Bell. Her PhD thesis was titled "Clinical and Laboratory Investigation into Heroin and Opioid Overdose Risk". Dr. Tas's research centers on opioid overdose mechanisms, opioid use disorder treatments, and health interventions to reduce drug-related deaths. She investigates experimental drug studies and develops wearable technologies for overdose detection. Her work aims to understand the physiological underpinnings of overdose and create practical tools for real-world overdose prevention, particularly in high-risk populations. Her recent publications (2020-2025) focus on innovative approaches to prevent opioid overdose deaths, including wearable biosensors (e.g., PneumoWave) and mHealth technologies. She explores risk factors for respiratory depression and the acceptability of detection devices among people who use opioids. Her work bridges laboratory models of overdose with clinical applications in supervised injecting facilities and community settings. Dr. Tas was awarded the following scientific award: Addictions Clinical Academic Group (CAG) Early Career Research Prize (2022) She contributes to teaching by supervising MSc Addiction Studies projects and teaching in the BSc Psychology "Addictions" and "Choices" modules. Additionally, she has been involved in public engagement, including school workshops and the art-science project "Heroin Bodies". Dr. Tas is part of the Drugs Research Group within the Addictions Department at King's, led by Professors John Strang and John Marsden. Her current work involves collaboration on projects related to opioid overdose and wearable technologies.

Daniel B. Neillمشاهده پروفایل

استاد

• Machine Learning
• Public Health
• Urban Analytics
• +۵ مورد دیگر

Daniel B. Neill is a Professor of Computer Science, Public Service, and Urban Analytics at New York University (NYU), jointly appointed across the Courant Institute of Mathematical Sciences, Robert F. Wagner Graduate School of Public Service, and the Center for Urban Science and Progress (Tandon School of Engineering). He also serves as the Director of the Machine Learning for Good Laboratory (ML4G) and is affiliated with NYU's Center for Data Science and Tandon Department of Computer Science and Engineering. Education: Ph.D. in Computer Science, Carnegie Mellon University M.S. in Computer Science, Carnegie Mellon University M.Phil. in Computer Speech, Cambridge University Research Interests: Dr. Neill's research focuses on developing novel machine learning methods for social good, with applications in disease surveillance (e.g., early outbreak detection), healthcare (e.g., anomalous care patterns), and urban analytics (e.g., predicting citizen needs). He also explores algorithmic fairness , causal inference , and pre-syndromic surveillance using unstructured data. His work bridges theoretical machine learning with real-world policy challenges, collaborating with health departments, hospitals, and city governments to deploy data-driven tools that enhance public health, safety, and security. Scientific Awards & Honors: NSF CAREER Award NSF Graduate Research Fellowship IEEE Intelligent Systems' "Top Ten AI Researchers to Watch" Yelp Dataset Challenge Winner Hidden Signals Challenge Runner-Up (DHS) Grants & Funding: He has received significant funding from the National Science Foundation (NSF), including grants on fairness in AI (IIS-2040898), bias in urban analytics (IIS-1926470), and others. He also acknowledges support from UPMC, MacArthur Foundation, and Richard King Mellon Foundation. Laboratory & Leadership: He directs the Machine Learning for Good Laboratory (ML4G) at NYU, focusing on AI for social impact. He previously co-directed NYU's Urban Initiative (2019-2022) and led the Event and Pattern Detection Laboratory at Carnegie Mellon University.

Aaron J. Chalfinمشاهده پروفایل

دانشیار

• Criminology
• Policing
• Place-Based Crime Prevention
• +۵ مورد دیگر

Aaron J. Chalfin serves as Associate Professor and Graduate Chair of Criminology within the Department of Criminology at the University of Pennsylvania's College of Liberal and Professional Studies. He maintains significant external affiliations as a Senior Fellow at the Niskanen Center, faculty research fellow at the National Bureau of Economic Research, and research affiliate at the University of Chicago Crime Lab. His academic foundation includes: PhD in Public Policy, University of California, Berkeley (2013) MA in International and Development Economics, Yale University (2004) BS in Industrial & Labor Relations, Cornell University (2003) Chalfin's research program centers on policing economics, officer behavioral preferences, place-based crime prevention strategies, and victimization determinants. He concurrently advances methodological rigor in social science through innovations in measurement error correction, spatial crime concentration metrics, and administrative data linkage techniques. His empirical approach consistently bridges theoretical criminology with practical policy evaluation. Recent publications reveal evolving research trajectories across bias-motivated violence measurement during pandemics, low-cost gun violence interventions, racial disparities in traffic fatalities, and methodological improvements for policy analysis. This body of work demonstrates sustained commitment to evidence-based criminal justice solutions through experimental and quasi-experimental designs. His ongoing collaboration with the University of Chicago Crime Lab exemplifies integration between academic research and real-world crime laboratory operations, focusing on scalable public safety innovations.

Trevor Goodyearمشاهده پروفایل

استادیار

• Substance Use
• Mental Health
• LGBTQ+ Health
• +۳ مورد دیگر

Trevor Goodyear is an Assistant Professor at the University of British Columbia (UBC) Faculty of Applied Science, School of Nursing. His research explores substance use, mental health, and health equity among marginalized populations, particularly 2S/LGBTQ+ youth and people who inject drugs. Education: MSN, MPH, PhD Research Interests: Harm reduction, LGBTQ+ health, mental health, public health, health equity, social determinants of health His recent work examines harm reduction strategies, structural vulnerabilities, and health narratives in urban drug scenes. Publications analyze cannabis use, overdose prevention, conversion practices, and the intersection of gender identity with substance use. His research employs qualitative methods like photovoice and narrative analysis to center marginalized voices. Key trends in his articles include the role of stigma in healthcare, policy implications of substance use research, and the impact of the COVID-19 pandemic on mental health disparities. He advocates for evidence-informed policies and community-driven interventions to address systemic inequities.

Victoria H. Arrandaleمشاهده پروفایل

استادیار

• Occupational Exposure Assessment
• Epidemiological Surveillance
• Intervention Effectiveness
• +۲ مورد دیگر

Dr. Victoria Arrandale is an Assistant Professor in the Occupational & Environmental Health Division at the University of Toronto's Dalla Lana School of Public Health. Her research program targets occupational exposure assessment and prevention strategies for workplace hazards. Key studies investigate asbestos-related disease surveillance , e-waste recycling risks , and intervention effectiveness . Current projects include predictive modeling for opioid overdose risk and health impacts of flame retardants in nail salons and firefighting. She directs the Centre for Occupational Disease Prevention and contributes to Ontario's occupational policy through the WSIB Scientific Advisory Table. Her teaching covers occupational hygiene and exposure assessment methodologies.

Taylor McLindenمشاهده پروفایل

استاد پژوهش

• Epidemiology
• Causal inference
• Administrative health data
• +۵ مورد دیگر

Taylor McLinden, PhD is an Adjunct Research Professor in the Department of Epidemiology and Biostatistics at Western University's Schulich School of Medicine and Dentistry. He serves as the Manager of the Health Data Research Network Canada (HDRN Canada) Pragmatic Trials Training Program and holds positions at ICES Western, HDRN Canada, and the London Health Sciences Centre. Previously, he worked as a Scientific Officer at the British Columbia Centre for Excellence in HIV/AIDS and completed postdoctoral training at the same institution. Dr. McLinden received his PhD in Epidemiology from McGill University (2013-2017), an MSc in Epidemiology from the University of Guelph (2011-2013), and an Honours BSc in Biomedical Sciences from Brock University (2007-2011). His research focuses on epidemiology, causal inference, and administrative health data analysis, with particular expertise in HIV/AIDS research, social determinants of health, food insecurity, and pragmatic trials methodology. Dr. McLinden has made significant contributions to understanding the intersection of HIV, overdose crises, housing stability, and social determinants of health among marginalized populations in British Columbia. His recent publications demonstrate a strong emphasis on population health research using linked administrative data, with particular attention to HIV outcomes, health disparities, and methodological innovations in epidemiologic research. His work often addresses critical public health challenges including the overdose crisis, social isolation among people living with HIV, and the impact of structural factors on health outcomes. Dr. McLinden has secured significant research funding, including a CIHR Operating Grant ($480,992 over 2 years) focused on the impact of the COVID-19 pandemic on drug overdoses among people with and without HIV, and a CIHR Project Grant ($994,500 over 5 years) addressing engagement of marginalized populations in primary health care in Vancouver's downtown east side. As Manager of the HDRN Canada Pragmatic Trials Training Program, Dr. McLinden plays a key role in building capacity for pragmatic clinical trials across Canada. His work bridges academic research with practical health system applications, contributing to evidence-informed healthcare decision-making through rigorous epidemiologic methods.

• Medical Education
• Diversity, Equity, and Inclusion
• Graduate Medical Education
• +۱۲ مورد دیگر

Michelle Guy, MD is a Professor of Medicine at the University of California, San Francisco (UCSF), School of Medicine, and a key figure in medical education and health equity. She is affiliated with the Department of Medicine and the Division of General Internal Medicine, where she serves as Director of Diversity for Graduate Medical Education (GME) and Director for Equity and Anti-Racism Continuing Education in the UCSF Differences Matter initiative. Professor, Department of Medicine, UCSF School of Medicine Director of Diversity, Graduate Medical Education Director for Equity and Anti-Racism Continuing Education, Differences Matter Member, Haile T. Debas Academy of Medical Educators Gold-Headed Cane Faculty Inductee Her educational background includes a B.A. in Comparative Literature from the University of Michigan, an M.D. from the University of Missouri–Columbia, and residency and chief residency training at Cambridge Health Alliance/Harvard Medical School. University of Michigan: B.A., Comparative Literature University of Missouri–Columbia: M.D., 2000 Cambridge Health Alliance/Harvard Medical School: Residency and Chief Residency, 2000–2003 UCSF: Diversity, Equity, and Inclusion Champion Training, 2017 Dr. Guy’s research and professional interests center on creating inclusive learning and clinical environments. She is a national leader in training faculty to recognize and interrupt microaggressions, mitigate bias in virtual interviews, and promote holistic review in residency selection. Her work in medical education emphasizes mentoring across differences, inclusive leadership, and curriculum development for equity. She also specializes clinically in Primary Care and Obesity Medicine, teaching obesity management to medical students and contributing to the American Board of Obesity Medicine (ABOM) as an item writer and board member. Her publications reflect a focus on improving resident training and clinical safety, particularly in substance use disorders. Both of her recent articles involve interventions to enhance resident competence in addiction medicine—one on naloxone co-prescribing and another on SBIRT training assessment—highlighting her commitment to evidence-based, patient-centered care and educational innovation. Dr. Guy has received significant recognition for her contributions: Excellence in Clinical Care, Robert Crede Award (2007) Marin Magazine Top Physician, Primary Care (2015) UCSF Medical Center Exceptional Physician Award (2015) Induction into the Haile T. Debas Academy of Medical Educators (2017) Gold-Headed Cane Faculty Inductee (2021) She actively advises and leads institutional initiatives rather than traditional graduate students, with leadership roles in faculty development, GME diversity strategy, and national lectures on inclusive education. She is deeply involved in the UCSF Differences Matter program and the Academy of Medical Educators’ Diversity Committee. Her work continues to shape equitable practices in medical training and patient care across the country.

Amanda Fallin-Bennettمشاهده پروفایل

دانشیار

• Tobacco Use
• Substance Abuse
• Recovery Frameworks
• +۷ مورد دیگر

Amanda Fallin-Bennett, Ph.D., is an Associate Professor at the University of Kentucky College of Nursing , with affiliations in the Cancer Prevention and Control Research Program and the Markey Cancer Center. Her work focuses on substance use , harm reduction , and health equity , particularly for vulnerable populations. Education: Doctor of Philosophy (2011), University of Kentucky Master of Science in Nursing (2009), University of Kentucky Bachelor of Science in Nursing (2007), University of Kentucky Her research explores polysubstance use , recovery frameworks , and public health policy , with recent articles addressing fentanyl test strip utilization , recovery capital in justice-involved women , and reproductive health access for recovery communities. She emphasizes health equity in tobacco control and social justice in substance use prevention. Scientific Awards: Nursing Grant Scholars (2016) Research Protégé of the Year (2019) Vernon Johnson Recovery Advocate of the Year (2019) Scholar Award (2017) Research Award (2019) She actively leads grants like the UK Harm Reduction Hub and Smoke-Free Policy and Behavioral Health initiatives, collaborating with Vital Strategies and KY Cabinet for Health and Family Services. Her work spans opioid use disorder , tobacco cessation , and policy implementation in rural Southern states.

Andrew Curtisمشاهده پروفایل

استاد

• Spatial Epidemiology
• GIS Applications in Public Health
• Spatial Data Collection in Challenging Environments
• +۵ مورد دیگر

Dr. Andrew Curtis is a Professor in the Department of Population and Quantitative Health Sciences at Case Western Reserve University's School of Medicine. He also holds a joint appointment in the Department of Anthropology, College of Arts and Sciences. His research focuses on spatial epidemiology, context-driven spatial data collection, and spatial confidentiality, with methodological expertise in geospatial data collection and analysis. He previously directed the WHO Collaborating Center for Remote Sensing and Public Health and has advised numerous public health agencies internationally. His work addresses health disparities at neighborhood scales, disaster response, and spatial syndromic surveillance. Dr. Curtis has mentored 10 PhD graduates now working in academia and public health sectors globally. Education includes a PhD in Geography from SUNY Buffalo (1995), MA in Geography from SUNY Buffalo (1991), and a BA from Portsmouth Polytechnic (1987). He has taught courses in GIS for health, medical geography, and global health. His advisory roles include collaborations with the CDC, Red Cross, and public health departments in Ohio and internationally. His research has been applied to cholera outbreaks, opioid overdose patterns, and pandemic response strategies. He co-edited a special issue on health geography and serves on the editorial board of the Annals of the Association of American Geographers. Dr. Curtis' spatial video methodologies have enabled fine-scale mapping in informal settlements, disaster zones, and conflict-affected areas. His recent work includes geospatial support for Ohio hospitals during the pandemic and energy vulnerability analysis. He emphasizes participatory research and context-enriched data collection to bridge gaps between health research and actionable policy.